Skip to main content
Log in

Bortezomib/doxorubicin

Reversible posterior leukoencephalopathy syndrome in an elderly patient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Rebora AE, Regesta G.Reversible posterior leukoencephalopathy: A possible threat for psoriatic patients treated with biological agents. Journal of the European Academy of Dermatology and Venereology 24: 97-98, No. 1, Jan 2010. Available from: URL: http://dx.doi.org/10.1111/j.1468-3083.2009.03317.x - Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bortezomib/doxorubicin. React. Wkly. 1290, 14 (2010). https://doi.org/10.2165/00128415-201012900-00038

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012900-00038

Keywords

Navigation